The toxicity of DL-methionine and methionine hydroxy analog infused into the tureen or abomasum was gauged by relative feed consumption. A continuous intraruminal infusion of at least 3 days' duration of DL-methionine equivalent to about 2.5% or more of dietary dry matter intake was required to reach a toxic amount. This was approximately four 6mes the amount necessary when it was infused into the abomasum. Methionine hydroxy analog equivalent to about 1% or more of dietary dry matter intake was toxic when infused into either tureen or abomasum. Th/s is in large excess of suggested amounts of analog supplementation. Reduced palatability is likely to occur in advance of reduced intake due to toxicity.
Introduction
Supplementation of dairy rations with methionine hydroxy analog (DL-a-hydroxy 7-methyl mercapto butyrate-calcium) has increased milk fat content and production of 4% fat-corrected milk (3, 5) . The first of these studies employed two amounts of methionine hydroxy analog supplementation. Reduced feed consumption was associated with higher supplementation (80 vs. 40 g/cow per day), and it was suggested that higher supplementation lowered palatability.
There is abundant evidence that methionine is one of the most toxic amino acids. Largely on the basis of experiments with rats, Harper et al. (4) concluded that consumption of methionine at four times its requirement resuits in growth depression and tissue damage Received December 10, 1974.
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when it is incorporated into a diet low in protein. The relative toxicity of excess methionine to most animal species (4) suggests that 80 g/cow per day of methionine hydroxy analog could produce toxicity as well as decrease palatability. Therefore, this experiment was designed to determine the toxicity of methionine and methionine hydroxy analog by infusing graded amounts of each into the rnmen and abomasum. A decrease in feed dry matter consumption was the criterion for toxicity.
Experimental Procedure
Three Holstein cows with abomasal cannulae, one Holstein and one Jersey cow with ruminal cannulae, and four Holstein steers with ruminal cannulae and weighing approximately 450 kg were in this study. The abomasum was cannulated with a 75-ml Bardex urinary catheter 2 which was satisfactory for infusion. The catheter bulb, normally inflated with 40 to 50 ml of water, could be deflated and the entire catheter removed for easy cleaning or replacement. The fistula would close permanently in approximately 1 wk after removal of the catheter. This was an advantage because it allowed experimental animals to revert to their original condition.
Animals were placed individually on experiment over approximately 3 yr. Each animal first received an infusion of water (control), and then an infusion of either DL-methionine or methionine hydroxy analog. Normally there was a series of four or more periods of either all ruminal infusions or all abomasal infusions with any given animal. Infusion periods varied from 3 to 14 days with most control infusion periods lasting 7 days and most treatment periods lasting 14 days. Variance resulted when extreme reductions in feed intake at high methionine or methionine hydroxy analog necessitated discontinuance of infusion. A transition time of 2 to 7 days was allowed for normalization of feed intake following amino add infusion; thus any carry-over effect of the preceding treatment period on the following control period was minimized. Methionine or methionine hydroxy analog dissolved daily in 6 and 16 liters of water, respectively, was pumped into the rumen or abomasum continuously throughout each experimental period. An equal amount of water (6 or 16 liters) was used for the control infusion.
Dry matter consumption was measured during the last 6 days of most periods. When large amounts of metlaionine or methionine hydroxy analog were infused, feed intake was near normal on the 1st day but approached zero on the 3rd or 4th day. Feed intake was averaged over the entire 3-or 4-day period in these cases. This procedure tended to give an upward bias to feed intake values during the heavy infusion rates.
Cows in this experiment were either in the latter stages of lactation or were not lactating and were i to 4 mo from parturition. Since this experiment was over 3 yr with fistulated animals momentarily uncommitted to other experiments, it was a matter of convenience to feed a ration being consumed currently by other cattle in the barn. This resulted in the feeding of several different rations through the experiment. The ration used most frequently consisted of corn silage ad libitum, plus 2.3 kg alfalfa hay/cow per day. In addition, 4.5 to 10 kg grain/cow per day were fed. Other rations consisted of either all alfalfa hay fed ad libitum or alfalfa hay plus 4.5 kg grain/cow per day. Dry matter content of eom silage was determined by toluene distillation, and oven drying was used to determine dry matter content of hay and grain. Animals were fed twice daily, and feed refusals were measured daily. Table 1 shows the effect of ruminal infusion of DL-methionine on feed intake. An empirical statistical evaluation of the data in Table 1 was made by calculating the mean and standard deviation of dry matter intake (expressed as a percent of intake during the control period) eehen small amounts of amino acids were infused. The data for the mean are indicated by brackets in each table. Methionine toxicity was considered operative when feed intake during amino acid infusion was less than the control by at least two standard deviations. This is indicated in the last column by an asterisk.
Results
Intraruminal infusion of DL-methionine in excess of an amount equivalent to approximately 2.5% of dry matter intake resulted in a reduction of dry matter intake. This amount, therefore, was considered as a potentially toxic percent of dietary DL-methiortine for cattle. Table 2 shows the effect of intraruminal infusion of methionine hydroxy analog on feed intake. More information is needed with small amounts of methionine analog infusion, but it appeared that feed intake was reduced when the analog exceeded an amount equal to approximately 1% of the ration dry matter. Unlike the sets of data in Tables 1, 3 , and 4, an insufficient number of small or innocuous rumen infusions of methionine hydroxy analog were made. Therefore, an arithmetic average of the three standard deviations in Tables 1,  3 , and 4 was used as an estimated standard deviation from an assumed mean of 100%. Since amounts equal to or in excess of 2,7% of the ration dry matter were quite toxic, infusion Feed intake values accompanied by an asterisk are more than two standard deviations below the relative feed intake of 100~. Because an insufficient number of low level infusions were made, the arithmetic average of the three standard deviation values showu in Tables 1, 3 , and 4 was used as the standard deviation in this table.
,b Relative feed intake during the last day of a 3-or 4-day infusion period.
periods were only of 3 or 4 days' duration.
Feed intake values shown were obtained by averaging all 3 or 4 days. Values in parentheses represent feed intake on the last day of the 3-or 4-day infusion. With the larger amounts of analog infusion, feed intake dropped to virtually zero over 3 to 4 days. Table 3 shows the relationship between dry matter intake and the quantity of DLmethionine infused into the abomasum. An insufficient number of infusions were made with large amounts of methionine, thereby making it difficult to establish a toxicity tba'eshold. Amounts of DL-methionine in excess of .6% "Feed intake values accompanied by an asterisk are more than two standard deviations below intake with low or nontoxic amounts of infused mothionine hydroxy analog.
of ration dry matter were required, however, before there was any evidence of a reduction in feed intake. Table 4 contains data relating dry matter intake and quantity of methionine hydroxy analog infused into the abomasum. Feed intake remained stable until the amount of analog infused equalled about 1% of dry matter intake. Increasing the amount of analog above this reduced feed intake.
Discussion
As pointed out earlier, feed intake values were biased upward in those instances where large amounts of methionine or the analog were infused. Feed intake actually decreased more precipitously than is indicated in the tables. The point of onset of toxicity would not be affected, however.
Based upon molecular weight, 113 g of the calcium salt of methionine hydroxy analog would be the molar equivalent of 100 g of DLmethionine. On this basis alone, methionine hydroxy analog would be slightly less toxic than an equal weight of DL-methionine.
With ruminal infusion, more than twice as much DL-methionine is required as methionine analog to reach a point of toxicity. This probably reflects the greater resistance of metionine hydroxy analog to microbial destruction in the rumen (1) . Cows consuming 15 kg of dry matter would have to consume about 150 g of methionine hydroxy analog before toxicity problems would develop. This is about twice the amount used in the early studies (3) and is considerably higher than the 25 g/day currently suggested. With abomasal infusion, about twice as much methionine hydroxy JOURNAL OF DAIRY SCIENCE VOL. 58, NO. 4 analog as DL-methionine was required to achieve equivalent depression in feed intake.
One-fourth as much methionine infused into the abomasum as the rumen decreased feed intake. Methionine hydroxy analog appeared to reduce feed intake at similar amounts with both infusion sites -about 1% of ration dry matter. Again, it appeared that much of the methionine infused into the rumen was degraded while the analog was much more resistant. Belasco (1) reported that, during two separate 4-h incubation studies with rumen fluid, 45 and 96% of the added L-methionine was metabolized, and only 9 and 54% of the added methionine hydroxy analo~ was degraded. Only small amounts of [14C] L-methionine or analog were used by Belasco. It is reasonable to expect that a larger percentage of the added methionine or analog would be degraded if only a small quantity were used rather than a large amount. The heavy infusion rates in this experiment may have exceeded the catabolic capabilities of the microorganisms for these two compounds.
Rats and chicks have reduced growth rates when supplemented methionine exceeds 1 to 2% of the total diet (4). Cattle in this study reduced their feed consumption with abomasaI infusion of methionine equal to about .6%. This suggests that cattle, and perhaps ruminants more generally, are less able to tolerate large amounts of methionine. The ruminant is protected from extreme amounts of absorbed nutrients, including amino acids, by the modulating effect of the rumen fermentation. In contrast, the nonruminant copes directly with extremes in diet composition. An interesting comparison could be made between meta-belie homeostatic abilities of nonruminants and those of ruminants when fermentation is circumvented. Such comparisons, however, should be based upon isocalorie diets (metabolizable energy) since the less digestible fibrous rations typically fed ruminants could lead to erroneous conclusions.
So-called toxic amounts, as referred to in this study, of methionine or its analog are really amounts required to reduce feed intake. It can be argued effectively that it is stretching the point to call this toxicity. However, in view of numerous studies relating feed intake, growth, and pathological changes of tissue (3) to excessive methionine consumption, the term "toxiC' appears appropriate. The way in which excessive methionine intake results in tissue damage is not clear, but a recent review of methionine toxicity is available (2) .
Proposed methionine or methionine analog supplementation of lactating cows mandates establishing limits of safety. Methionine hydroxy analog supplementation at the currently suggested 25 g/cow per day appears well below the point of potential toxicity. Reduced palatability of the calcium salt of methionine hydroxy analog is likely to occur before toxicity is reached.
